GlaxoSmithKline
GSK
#216
Rank
$95.75 B
Marketcap
$47.27
Share price
-2.48%
Change (1 day)
35.79%
Change (1 year)

GlaxoSmithKline (GSK) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : $61.28 Billion USD

According to GlaxoSmithKline's latest financial reports the company's total liabilities are $61.28 Billion USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

GlaxoSmithKline - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31$58.19 B-1.14%
2023-12-31$58.87 B-2.77%
2022-12-31$60.55 B-22.34%
2021-12-31$77.96 B-4.06%
2020-12-31$81.27 B1.05%
2019-12-31$80.42 B16.49%
2018-12-31$69.04 B-3.41%
2017-12-31$71.48 B7.05%
2016-12-31$66.77 B1.11%
2015-12-31$66.04 B18.78%
2014-12-31$55.60 B-1.65%
2013-12-31$56.53 B0.67%
2012-12-31$56.15 B12.02%
2011-12-31$50.13 B-0.03%
2010-12-31$50.14 B-3.52%
2009-12-31$51.97 B14.12%
2008-12-31$45.54 B8.57%
2007-12-31$41.94 B34.68%
2006-12-31$31.14 B-7.96%
2005-12-31$33.83 B6.88%
2004-12-31$31.66 B14.27%
2003-12-31$27.70 B15.68%
2002-12-31$23.95 B21.76%
2001-12-31$19.67 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
AstraZeneca
AZN
$68.48 B 11.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
$115.63 B 88.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$77.63 B 26.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$62.53 B 2.04%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
$66.02 B 7.74%๐Ÿ‡ซ๐Ÿ‡ท France
Teva Pharmaceutical Industries
TEVA
$32.60 B-46.80%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Dynavax Technologies
DVAX
$0.41 B-99.33%๐Ÿ‡บ๐Ÿ‡ธ USA